Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation
Observational Study of Basal Cell Carcinoma Operated at Montpellier University Hospital and Millau Hospital From February 2020 to February 2021 - Study of Correlation Between Localisation and Recurrence, and Other Criterias
.During one year all the resected basal cell carcinomas (BCC) analyzed in Montpellier University Hospital Anatomopathology unit were included in this study. Localisation and histological characteristics were collected. All the recurrences of BCC were searched from the medical records (or histopathology request form).
From 804 BCC, 48 were recurrent BCC with or without complete first resection. Patients with recurrent BCC were contacted to obtain agreement and more informations about the first resection and some clinical informations like sun exposure and phototype.
The statistical analysis focused on the localisation of recurrent BCC (with a complete first resection) compared to localisations of primary BCC in this population. The goal was to identified localisations with an increased risk of recurrences.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Montpellier, Frankrike, 34295
- UHMontpellier
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Cohort :
All the resected BCC during one year in Montpellier University Hospital and Millau Hospital (both analyzed in anatomopathology unit in Montpellier University Hospital).
Cases :
All the cases of recurrent BCC, found after research in medical records or histopathology request form.
Beskrivning
Cohort :
Inclusion criteria:
- Patients with resected BCC
Exclusion criteria:
- Biopsies of BCC,
- revised surgery of incomplete resection.
Cases :
Inclusion criteria:
-Recurrent BCC with complete first resection
Exclusion criteria:
- Recurrent BCC with incomplete first resection, Patients with Gorlin syndrome (a genetic disease that increase risk of BCC)
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
|---|
|
recurrent BCC
|
|
resected BCC
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
- Determined For each localisation the number of primary and recurrent BCC and analysis of localisation with higher risk of BCC
Tidsram: 1 day
|
- Determined For each localisation the number of primary and recurrent BCC and analysis of localisation with higher risk of BCC
|
1 day
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Analysis of correlation between localisation and histology characteristics
Tidsram: 1 day
|
Analysis of correlation between localisation and histology characteristics
|
1 day
|
|
Analysis of correlation between histological type and recurrence risk
Tidsram: 1 day
|
Analysis of correlation between histological type and recurrence risk
|
1 day
|
|
Analysis if there is a difference between first resection histological type and the recurrent histological type
Tidsram: 1 day
|
Analysis if there is a difference between first resection histological type and the recurrent histological type
|
1 day
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Sophie Pons, Resident, University Hospital, Montpellier
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- RECHMPL21_0156
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Basalcellscancer
-
Fundació d'investigació Sanitària de les Illes...Hospital Son EspasesRekryteringFörsta CarpoMetacarpal artros | Basal tumsartrosSpanien
-
Hiroshima UniversityThree Peace Co., Ltd., JapanAvslutadLåg basal kroppstemperaturJapan
-
Assiut UniversityHar inte rekryterat ännuBasal ganglionisk blödning
-
Second Affiliated Hospital, School of Medicine,...Ningbo Medical Center Lihuili Hospital; Second Affiliated Hospital of Wenzhou... och andra samarbetspartnersRekryteringBasal ganglia hematomKina
-
University Hospital, LinkoepingAvslutadKardiovaskulära riskfaktorer | Basal ämnesomsättningSverige
-
Second Affiliated Hospital, School of Medicine,...First Affiliated Hospital of Fujian Medical University; Taizhou Hospital; The First Affiliated Hospital, University of Science and Technology of China och andra samarbetspartnersRekryteringBasal ganglia hematomKina
-
Assistance Publique - Hôpitaux de ParisAvslutad
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Anhui Medical University; Huashan Hospital och andra samarbetspartnersHar inte rekryterat ännu
-
Mabwell (Shanghai) Bioscience Co., Ltd.Har inte rekryterat ännuAvancerat clear cell renal cell carcinom
-
Clearmind Biomedical Inc.Chang Gung Memorial HospitalAvslutadHjärnblödning | Intracerebral blödning | Basal ganglia blödning | Intrakraniell blödningTaiwan